InvestSMART

Cochlear Limited (ASX:COH)

ALERT: Price-sensitive ASX Announcement for COH
Current share price for COH : $124.960 -120.68 (-49.13%)+
Announcement
Release
13 Feb 2026 7:33AM
Price at Release
$245.640
Full Release
download
Summary
Cochlear Limited reported their financial results for the half-year ending December 2025, highlighting a 1% increase in sales revenue to $1,176 million, though underlying net profit decreased by 9% to $195 million. The company launched the Cochlear Nucleus Nexa System, a significant development in cochlear implant technology, expected to drive growth in the second half of the fiscal year. The interim dividend remains steady at $2.15 per share. Challenges included a longer-than-anticipated product registration and contract renewal process, impacting the first half's performance. Looking forward, Cochlear anticipates strong growth in the second half of FY26, with the Nucleus Nexa System's broad availability and expected increases in services and acoustics segments. However, currency fluctuations could impact the underlying net profit. The company continues to invest in R&D and market growth activities, aiming for long-term sustainable growth.
Key Points
  • Sales revenue increased 1% to $1,176 million.
  • Underlying net profit decreased 9% to $195 million.
  • Launch of Cochlear Nucleus Nexa System expected to drive growth.
  • Interim dividend steady at $2.15 per share.
  • Longer-than-anticipated registration and contract renewal process impacted first-half performance.
  • Strong second-half growth anticipated with broad availability of Nexa System.
  • Investment in R&D and market growth activities continues.
  • Currency fluctuations could impact underlying net profit.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.